<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03571776</url>
  </required_header>
  <id_info>
    <org_study_id>PR031/18</org_study_id>
    <nct_id>NCT03571776</nct_id>
  </id_info>
  <brief_title>Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial</brief_title>
  <official_title>Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter study is to compare the ovarian reserve after alcohol
      sclerosis of the endometriomas against conventional surgery (AMH, follicle stimulating
      hormone (FSH) and antral follicles count) as well as the complications and costs between the
      2 procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical Trial Phase III, Multicenter, National, open, parallel-group assignment 1: 1,
      stratified by age, previous oophorectomy and uni- or bilateral ovarian involvement. Patients
      with suspected ovarian endometrioma by ultrasound will be randomized into 2 groups: (a) Study
      Group: echoguided aspiration plus sclerosis with alcohol; (B) Control group: Laparoscopic
      Cystectomy. Pre-treatment, and 6 months after treatment, AMH values will be determined.
      Complications, recurrences and costs from each treatment will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 5, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter, National, assignment 1: 1, stratified by age, previous oophorectomy and uni- or bilateral ovarian involvement.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline AMH Test</measure>
    <time_frame>prior and 6 months after both procedures</time_frame>
    <description>the value of AMH in ng/mL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline antral follicles count</measure>
    <time_frame>prior and 6 months after both procedures</time_frame>
    <description>US antral follicles count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 month after the procedure</time_frame>
    <description>number of participants with complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>1 month after the procedure</time_frame>
    <description>costs (euros) of the procedure plus cost of their complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Pain</measure>
    <time_frame>prior and 6 months after both procedures</time_frame>
    <description>Visual Analog Score for pain (ranged 1-10). Patients pain evaluation fron 1 no pain to 10 maximum pain considered</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Endometrioma</condition>
  <condition>Fertility Disorders</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic ovarian cystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sclerotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>US-aspiration and alcohol sclerosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Laparoscopic ovarian cystectomy</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sclerotherapy</intervention_name>
    <description>US-aspiration and alcohol sclerosis</description>
    <arm_group_label>Sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uni- or bilocular endometrioma according ultrasounds

          -  Endometrioma size: 30-100 mm when symptoms were present and 50-100 mm if asymptomatics

          -  &gt; 3 months from diagnosis

          -  Ca125 &lt;200 IU/mL and human epididymis protein 4 (HE4) &lt; 70,

        Exclusion Criteria:

          -  Previous gynecological cancer

          -  Symptomatic severe extraovarian endometriosis

          -  Dermoid or high risk of malignancy cysts

          -  Pregnancy

          -  Mental disability
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amparo Garcia-Tejedor, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Bellvitge. IDIBELL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amparo Garcia-Tejedor, MDPhD</last_name>
    <phone>0034-660.22.34.17</phone>
    <email>agarciat@bellvitgehospital.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordi Ponce, MDPhD</last_name>
    <email>jponce@bellvitgehospital.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amparo Garcia-Tejedor, MDPhD</last_name>
      <phone>0034-660223417</phone>
      <email>agarciat@bellvitgehospital.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Coccia ME, Rizzello F, Cammilli F, Bracco GL, Scarselli G. Endometriosis and infertility Surgery and ART: An integrated approach for successful management. Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):54-9. doi: 10.1016/j.ejogrb.2007.11.010. Epub 2008 Feb 20.</citation>
    <PMID>18243485</PMID>
  </reference>
  <reference>
    <citation>Muzii L, Bianchi A, Crocè C, Manci N, Panici PB. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril. 2002 Mar;77(3):609-14.</citation>
    <PMID>11872220</PMID>
  </reference>
  <reference>
    <citation>Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):187-91. Japanese.</citation>
    <PMID>3283269</PMID>
  </reference>
  <reference>
    <citation>Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001 Jan;72(1):35-9.</citation>
    <PMID>11146075</PMID>
  </reference>
  <reference>
    <citation>Kafali H, Eser A, Duvan CI, Keskin E, Onaran YA. Recurrence of ovarian cyst after sclerotherapy. Minerva Ginecol. 2011 Feb;63(1):19-24.</citation>
    <PMID>21311417</PMID>
  </reference>
  <results_reference>
    <citation>Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012 Sep;97(9):3146-54. doi: 10.1210/jc.2012-1558. Epub 2012 Jun 20. Review.</citation>
    <PMID>22723324</PMID>
  </results_reference>
  <results_reference>
    <citation>Biacchiardi CP, Piane LD, Camanni M, Deltetto F, Delpiano EM, Marchino GL, Gennarelli G, Revelli A. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online. 2011 Dec;23(6):740-6. doi: 10.1016/j.rbmo.2011.07.014. Epub 2011 Jul 27.</citation>
    <PMID>22019621</PMID>
  </results_reference>
  <results_reference>
    <citation>Yazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, Hazout A. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009 Jul;19(1):121-5.</citation>
    <PMID>19573300</PMID>
  </results_reference>
  <results_reference>
    <citation>García-Tejedor A, Castellarnau M, Ponce J, Fernández ME, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results. Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:25-9. doi: 10.1016/j.ejogrb.2015.02.004. Epub 2015 Feb 16.</citation>
    <PMID>25739052</PMID>
  </results_reference>
  <results_reference>
    <citation>Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012 Dec;98(6):1531-8. doi: 10.1016/j.fertnstert.2012.08.009. Epub 2012 Sep 10. Review.</citation>
    <PMID>22975114</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 31, 2018</study_first_submitted>
  <study_first_submitted_qc>June 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>May 3, 2020</last_update_submitted>
  <last_update_submitted_qc>May 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Amparo Garcia-Tejedor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

